1van der Voort R, Kramer M, Lindhout E, et al. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions [ J ]. Leukoc Biol,2005, 77(5) : 739 -747. 被引量：1
2Schutyser E, Richmond A, Van Damme J, et al. Involvement of CC chemokine ligand 18 ( CCL18 ) in normal and pathological processes [J]. LeukoeBiol, 2005,78(1): 14 -26. 被引量：1
3Adema GJ, Hartgers F, Verstraten R, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells [ J ]. Nature, 1997, 387(6634) : 713 -717. 被引量：1
4Gunther C, Bello-Fernandez, Kopp T, et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells [J]. Immunol, 2005, 174(3): 1723-1728. 被引量：1
5Vulcano M, Struyf S, Scapini P, et al. Unique regulation of CCL18 production by maturing dendritic cells [ J]. Immunol, 2003, 170 (7) : 3843-3849. 被引量：1
6Struyf S, Schutyser E, Gouwy M, et al. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia[J]. Am J Pathol, 2003, 163(5) : 2065 -2075. 被引量：1
7Sun X, Cheng G, Hao M, et al. CXCLI2/CXCR4/CXCR7 chemokine axis and cancer progression [ J]. Cancer Metastasis Rev, 2010, 29 (4) : 709 -722. 被引量：1
8Sun X, Cheng G, Hao M, et al. CXCLI2/CXCR4/CXCR7 chemokine axis and cancer progression [ J ]. Cancer Metastasis Rev, 2010, 29 (4) : 709 -722. 被引量：1
9Pals ST, Gorter D J, Spaargaren M, et al. Lymphoma dissemination: the other face of lymphocyte homing [ J ]. Blood, 2007, i 10 ( 9 ) : 3102 -3111. 被引量：1
10Schrottner P, Leick M, Burger M, et al. The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact[J]. Ann Hematol, 2010, 89(5) : 437 -446. 被引量：1
2Hones T,Krohn A,BurgerM. Serum level of CC-chemokine lig-andl8 is increased inpatients with non-small-celllung cancer andcorrelates with survival time in adenocarcinomas[J].PLoS One,2012.741-746. 被引量：1
3Pettersen JS,Fuentes-Duculan J,Suarez-Farifias M. Tumor-associated macmphages in the cutaneous SCC microenvironment areheterogeneously activated[J].Invest Dermato1,2011.1322-1330. 被引量：1
4Chen J,Y Gong C. CCL18 from tumor-associated macrophage promotes breast cancer metastasis via PITPNM3[J].Cancer CeU,2011.541-555. 被引量：1
5Kollert F,Binder M,Probst C. CCL18--potential biomarker offibroinflammatory activity in chronic periaortitis[J].{H}Journal of Rheumatology,2012,(07):1407-1412. 被引量：1
6Wang Q,Li D,Zhang W. Evaluation of proteomics identified CCLl8 and CXCLl as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses[J].{H}International Journal of Biological Markers,2011.262-273. 被引量：1
7Zohny SF,Fayed ST. Clinical utility of circulating matrix metallopmteinase-(MMP-7),CC chemokine ligand 18 (CCLl8)and CC chemokine ligand 1 1 (CCLll) as markers for diagnosis of epithelial ovarian cancer[J].Med Onc01,2010.1246-1253. 被引量：1
8Beasley V, Joshi PV, Singanayagam A, et at. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis, 2012, 7(7):555-569. 被引量：1
9Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors forchronic obstructive pulmonary disease. PLoS One, 2012, 7(5):e37978. 被引量：1
10Sethi S, Mahler DA, Marcus P, et al. Inflammation in COPD: implications for management. Am J Med, 2012, 125(12):1162-1170. 被引量：1
